United States Eventing Association

Adequan® Continues Partnership with the USEA

The United States Eventing Association, Inc. (USEA) is happy to announce that long-time partner American Regent Animal Health, makers of Adequan® i.m. (polysulfated glycosaminoglycan), will continue their support of the USEA in 2023. Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final and a Contributing Sponsor of the USEA American Eventing Championships (AEC). The $60,000 Adequan® USEA Advanced Final will take place during the 2023 AEC at the Kentucky Horse Park in Lexington, Kentucky, this Aug. 29 through Sept. 3.

“We are so thankful for American Regent Animal Health and Adequan’s® continued support of the USEA and the eventing community as a whole,” said USEA CEO Rob Burk. “With the AEC returning to the Kentucky Horse Park in 2023, we are sure that the $60,000 Adequan® USEA Advanced Final will be an event you won’t want to miss. We look forward to another great year partnering with Adequan®!”

“For more than 30 years, Adequan® has been a strong supporter of horses and riders and we are thrilled to continue that tradition with the USEA,” said Beth Anderson, manager of sponsorships and events at American Regent Animal Health. “We’re looking forward to another exciting competition season in the sport of eventing.”

About the $60,000 Adequan USEA Advanced Final

The $60,000 Adequan® USEA Advanced Final will take place at the 2023 USEA American Eventing Championships presented by Nutrena Feeds at the Kentucky Horse Park in Lexington, Kentucky, Aug. 29—Sept. 3, 2023. Thanks to Adequan’s amazing support, the Adequan® USEA Advanced Final will bring together the country’s top riders to vie for $60,000 in prize money and the title of Adequan® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2023, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , CCI5*-L, World Championships or Olympic Games. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.

About the United States Eventing Association

The USEA is a non-profit 501(c)(3) educational organization committed to providing eventing enthusiasts with a competitive level suited to their individual skills. By assisting and educating competitors, event organizers, and officials; maintaining responsible safety standards; and registering qualified competitions and clinics, the USEA offers a strong and continuous training opportunity for an ever-expanding field of world-class competitors. Just as importantly, the USEA provides a means for all riders, regardless of age or ability, to experience the thrill of eventing. To learn more, visit www.useventing.com.

About American Regent Animal Health

American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0966